Literature DB >> 28117294

The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation.

Hani Alotaibi, Merve Tuzlakoğlu-Öztürk, Uygar Halis Tazebay1.   

Abstract

Iodide (I-) is an essential constituent of the thyroid hormones triiodothyronine (T3) and thyroxine (T4), and the iodide concentrating mechanism of the thyroid gland is essential for the synthesis of these hormones. In addition, differential uptake of iodine isotopes (radioiodine) is a key modality for the diagnosis and therapy of thyroid cancer. The sodium dependent iodide transport activity of the thyroid gland is mainly attributed to the functional expression of the Na+/I- Symporter (NIS) localized at the basolateral membrane of thyrocytes. In this paper, we review and summarize current data on molecular characterization, on structure and function of NIS protein, as well as on the transcriptional regulation of NIS encoding gene in the thyroid gland. We also propose that a better and more precise understanding of NIS gene regulation at the molecular level in both healthy and malignant thyroid cells may lead to the identification of small molecule candidates. These could then be translated into clinical practice for better induction and more effective modulation of radioiodine uptake in dedifferentiated thyroid cancer cells and in their distant metastatic lesions.

Entities:  

Year:  2017        PMID: 28117294      PMCID: PMC5283716          DOI: 10.4274/2017.26.suppl.11

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther        ISSN: 2146-1414


  103 in total

1.  Guidelines for human gene nomenclature.

Authors:  Hester M Wain; Elspeth A Bruford; Ruth C Lovering; Michael J Lush; Mathew W Wright; Sue Povey
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736

2.  Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid.

Authors:  C Koerber; C Schmutzler; J Rendl; J Koehrle; H Griesser; D Simon; C Reiners
Journal:  Clin Nucl Med       Date:  1999-11       Impact factor: 7.794

3.  Radioiodide transport in an iodide-concentrating tumor of thyroid gland.

Authors:  S H WOLLMAN; F E REED
Journal:  Am J Physiol       Date:  1960-09

Review 4.  Thyroid cancer: an overview.

Authors:  Masud Haq; Clive Harmer
Journal:  Nucl Med Commun       Date:  2004-09       Impact factor: 1.690

5.  Iodine deficiency and brain development.

Authors:  P Stubbe; F J Schulte; P Heidemann
Journal:  Bibl Nutr Dieta       Date:  1986

6.  Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.

Authors:  P H Eng; G R Cardona; S L Fang; M Previti; S Alex; N Carrasco; W W Chin; L E Braverman
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

Review 7.  Retinoic acid redifferentiation therapy for thyroid cancer.

Authors:  C Schmutzler; J Köhrle
Journal:  Thyroid       Date:  2000-05       Impact factor: 6.568

Review 8.  Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer.

Authors:  Jafaru Abu; Madu Batuwangala; Karl Herbert; Paul Symonds
Journal:  Lancet Oncol       Date:  2005-09       Impact factor: 41.316

9.  Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.

Authors:  F Grünwald; C Menzel; H Bender; H Palmedo; R Otte; R Fimmers; J Risse; H J Biersack
Journal:  J Nucl Med       Date:  1998-11       Impact factor: 10.057

Review 10.  Nuclear retinoid receptors and the transcription of retinoid-target genes.

Authors:  Julie Bastien; Cécile Rochette-Egly
Journal:  Gene       Date:  2004-03-17       Impact factor: 3.688

View more
  4 in total

1.  Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma.

Authors:  Ana Filipa Brito; Ana Margarida Abrantes; Ricardo Teixo; Ana Salomé Pires; Ana Cláudia Ribeiro; Rafael Fernandes Ferreira; Alexandra Fernandes; Tiago Puga; Mafalda Laranjo; Francisco Caramelo; Ilka Boin; Douglas M Jefferson; Ana Cristina Gonçalves; Ricardo Martins; Joana Rodrigues; Ilda Patrícia Ribeiro; Joana Barbosa De Melo; Ana Bela Sarmento-Ribeiro; Isabel Marques Carreira; Doroteia Souza; José Guilherme Tralhão; Maria Filomena Botelho
Journal:  Int J Oncol       Date:  2020-01-10       Impact factor: 5.650

Review 2.  The Role of Iodine for Thyroid Function in Lactating Women and Infants.

Authors:  Maria Andersson; Christian P Braegger
Journal:  Endocr Rev       Date:  2022-05-12       Impact factor: 25.261

3.  Optimal administration time of vitamin C after 131I therapy in differentiated thyroid cancer based on propensity score matching.

Authors:  Ye Liu; Yuhua Wang; Wanchun Zhang
Journal:  Front Surg       Date:  2022-09-22

Review 4.  Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?

Authors:  Marios Adramerinas; Dimitrios Andreadis; Konstantinos Vahtsevanos; Athanasios Poulopoulos; Kalliopi Pazaitou-Panayiotou
Journal:  Hormones (Athens)       Date:  2021-06-18       Impact factor: 2.885

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.